Market capitalization | $931.16m |
Enterprise Value | $576.50m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 0.10 |
P/S ratio (TTM) P/S ratio | 0.17 |
P/B ratio (TTM) P/B ratio | 1.62 |
Revenue growth (TTM) Revenue growth | 33.49% |
Revenue (TTM) Revenue | $5.59b |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
18 Analysts have issued a Agilon Health Inc forecast:
18 Analysts have issued a Agilon Health Inc forecast:
Sep '24 |
+/-
%
|
||
Revenue | 5,594 5,594 |
33%
33%
|
|
Gross Profit | -74 -74 |
148%
148%
|
|
EBITDA | -321 -321 |
162%
162%
|
EBIT (Operating Income) EBIT | -344 -344 |
143%
143%
|
Net Profit | -336 -336 |
279%
279%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Agilon Health, Inc. engages in providing necessary capabilities, capital, and business model for existing physician groups to create a Medicare-centric, globally capitated line of business. It offers Total Care Model that focuses exclusively on Medicare and manages the comprehensive healthcare needs of its members through subscription-like member per month arrangements with health plans or directly with Centers for Medical and Medicard services. The company was founded in 2016 and is headquartered in Long Beach, CA.
Head office | United States |
CEO | Steven Sell |
Employees | 1,117 |
Founded | 2016 |
Website | www.agilonhealth.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.